Myeloid mimicry enables kidney tumors to resist immunotherapy and worsen rapidly, study finds

Researchers at The University of Texas MD Anderson Cancer Center have found that renal medullary carcinoma (RMC) cells use an adaptive mechanism called “myeloid mimicry” to hide from the immune system and promote disease hyperprogression after…

Continue Reading

News Source: medicalxpress.com